PT  - JOURNAL ARTICLE
AU  - Gausdal, Gro
AU  - Micklem, David R
AU  - Blø, Magnus
AU  - Rayford, Austin
AU  - Alzhanova, Dina
AU  - Madeleine, Noëlly
AU  - Taverna, Josephine Amalia
AU  - Hung, Chia-Nung
AU  - Brekken, Rolf A
AU  - Chisamore, Michael
AU  - Gorcea-Carson, Claudia
AU  - Oliva, Cristina
AU  - McCracken, Nigel
TI  - 598 Bemcentinib + pembrolizumab show promising efficacy in metastatic NSCLC harbouring mutations associated with poor prognosis: exploratory sub-analysis from the BGBC008 trial (NCT03184571)
AID  - 10.1136/jitc-2023-SITC2023.0598
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A680--A681
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A680.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A680.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.